The following updates are from the Drug Policy Alliance. Thought you might enjoy hearing about positive progress.
The Rohrabacher-Blumenauer Amendment, which prevents the Justice Department from using federal funds to interfere with state medical marijuana programs, was approved until December 22, when federal spending will be revisited. (The legislation was tacked onto the federal funding bill.)
On Veterans Day, Governor Cuomo signed a bill allowing patients with post-traumatic stress disorder to access medical marijuana, an especially significant victory for veterans in New York State.
Walgreens joined CVS in carrying naloxone, a lifesaving opioid overdose-reversal drug, over-the-counter in pharmacies across the country.
California rolled back many punitive drug sentences with the passage of the RISE Act.
A recent Gallup poll showed 64% of Americans support legalizing marijuana use in the United States, the highest number in nearly five decades.
Senator Cory Booker introduced the Marijuana Justice Act, a groundbreaking marijuana legalization bill in Congress focused on racial equity.
In a significant win for drug policy reform advocates everywhere, Peru—traditionally a very conservative country on drug policy—approved the production, sale and use of medical marijuana.
Colorado scaled back its abusive use of civil asset forfeiture.
Nevada began legal sales of marijuana over the summer.
The Drug Policy Alliance brought together 1,500 drug policy advocates at this year’s Reform Conference.
Syringe access programs were legalized in Virginia, a state experiencing significant increases in opioid overdose and misuse.
The Atlanta city council voted unanimously to decriminalize marijuana.
New Jersey’s bail reform system saw successful implementation in its first year, a victory keeping thousands out of jail by making the processes more equitable.
Thanks for reading.
Do you have additional information? Do you disagree with the Drug Policy Alliance? I love hearing from you.
Warmest Regards, Michele Author, Busted www.michelekhoury.com Link to subscribe: http://michelekhoury.com/blog/